Catalyst Pharmaceuticals, Inc.
Simbol: CPRX
NASDAQ
14.72
USDPrețul de piață astăzi
21.9975
Raportul P/E
-0.6049
Raportul PEG
1.73B
MRK Cap
- 0.00%
Randament DIV
Catalyst Pharmaceuticals, Inc. (CPRX) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 585.64 | 137.6 | 298.4 | 191.3 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 19.8 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 177.76 | 53.5 | 10.4 | 6.6 | |||||||||||||||||||||
balance-sheet.row.inventory | 45.76 | 15.6 | 6.8 | 7.9 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 20.18 | 12.5 | 5.2 | 4.4 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 851.23 | 219.3 | 320.8 | 210.1 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 15.3 | 3.7 | 3.6 | 4 | |||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 720.84 | 194 | 32.5 | 0 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 720.84 | 194 | 32.5 | 0 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 396.9 | 16.5 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 119.5 | 38.3 | 18.7 | 23.7 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | -367.51 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 885.02 | 252.6 | 54.8 | 27.7 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 1736.24 | 471.9 | 375.6 | 237.8 | |||||||||||||||||||||
balance-sheet.row.account-payables | 27.2 | 14.8 | 4 | 2.8 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 1.43 | 0.4 | 0.3 | 0.3 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 24.14 | 0.7 | 8.7 | 0.1 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 13.31 | 3.2 | 3.6 | 3.9 | |||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | -1.3 | 0 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 1.79 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 113.97 | 60.2 | 53.3 | 0.2 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 47.78 | 8 | 17.6 | 3.9 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 14.03 | 3.2 | 3.6 | 3.9 | |||||||||||||||||||||
balance-sheet.row.total-liab | 290.86 | 84 | 75.2 | 31 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 0.43 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 404.32 | 121.3 | 49.9 | -26.3 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0.06 | 0 | 0 | -0.1 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1040.58 | 266.5 | 250.4 | 233.2 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1445.38 | 387.9 | 300.4 | 206.8 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1736.24 | 471.9 | 375.6 | 237.8 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 1445.38 | 387.9 | 300.4 | 206.8 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1736.24 | - | - | - | |||||||||||||||||||||
Total Investments | 396.9 | 16.5 | 0 | 19.8 | |||||||||||||||||||||
balance-sheet.row.total-debt | 14.4 | 3.6 | 3.9 | 3.9 | |||||||||||||||||||||
balance-sheet.row.net-debt | -571.24 | -134.1 | -294.5 | -167.6 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 71.41 | 71.4 | 83.1 | 39.5 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 32.88 | 33.1 | 1.2 | 0.2 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | -17.82 | -17.8 | 4.9 | 9.3 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 14.25 | 14.3 | 7.9 | 6.1 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -37.32 | -37.3 | 13.7 | 5 | ||||||||||||||||||||
cash-flows.row.account-receivables | -43.08 | -43.1 | -3.8 | -0.6 | ||||||||||||||||||||
cash-flows.row.inventory | -4.74 | -4.7 | 1.1 | -3.2 | ||||||||||||||||||||
cash-flows.row.account-payables | 10.82 | 10.8 | 1.2 | -1.5 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 25.34 | -0.3 | 15.3 | 10.4 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 80.2 | 79.9 | 5.2 | 0.3 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 143.6 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -115.52 | -198.5 | 0 | -1 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 10 | 0 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | -13.46 | -13.5 | -10 | -10 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 19.2 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | -243.81 | -81.5 | -10 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -293.5 | -293.5 | 9.2 | -11 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 2.79 | 2.8 | 4.1 | 4.1 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -6.9 | -12.1 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | -13.65 | -13.6 | 4.5 | -0.2 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -10.86 | -10.9 | 1.7 | -8.1 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -160.76 | -160.8 | 127 | 41.2 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 585.64 | 137.6 | 298.4 | 171.4 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 746.4 | 298.4 | 171.4 | 130.2 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 143.6 | 143.6 | 116 | 60.4 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -115.52 | -198.5 | 0 | -1 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | 28.08 | -54.9 | 116 | 59.4 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 398.2 | 398.2 | 214.2 | 140.8 | ||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 61.03 | 84.5 | 34.4 | 21.9 | ||||||||||||||||||||||
income-statement-row.row.gross-profit | 337.18 | 313.7 | 179.8 | 118.9 | ||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
income-statement-row.row.research-development | 93.15 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 47.02 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 86.69 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-expenses | 12.53 | 7.7 | 2.9 | 0.3 | ||||||||||||||||||||||
income-statement-row.row.operating-expenses | 250.37 | 226.9 | 78 | 66.6 | ||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 311.39 | 311.4 | 112.4 | 88.4 | ||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 3.6 | 0.3 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | -4.1 | 0 | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 86.69 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 7.7 | 7.7 | 2.9 | 0.3 | ||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 12.53 | 7.7 | 2.9 | 0.3 | ||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 7.7 | 7.7 | 2.9 | 0.3 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | -4.1 | 0 | ||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 32.81 | 33.1 | 1.2 | 0.2 | ||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 119.62 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.operating-income | 86.81 | 86.8 | 101.8 | 52.4 | ||||||||||||||||||||||
income-statement-row.row.income-before-tax | 94.51 | 94.5 | 104.7 | 52.7 | ||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 23.1 | 23.1 | 21.6 | 13.2 | ||||||||||||||||||||||
income-statement-row.row.net-income | 71.41 | 71.4 | 83.1 | 39.5 |
Întrebări frecvente
Ce este Catalyst Pharmaceuticals, Inc. (CPRX) totalul activelor?
Catalyst Pharmaceuticals, Inc. (CPRX) activele totale sunt 471907000.000.
Care este venitul anual al întreprinderii?
Venitul anual este 213256000.000.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.847.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este 0.263.
Care este marja de profit net a întreprinderii?
Marja profitului net este 0.179.
Care este venitul total al întreprinderii?
Venitul total este 0.218.
Care este Catalyst Pharmaceuticals, Inc. (CPRX) profitul net (venitul net)?
Profitul net (venitul net) este 71410000.000.
Care este datoria totală a firmei?
Datoria totală este 3557000.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 226860000.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 137636000.000.